Quanzhou Voke Health Industry Co., Ltd announced that it will receive CNY 380,220,800 on February 26, 2022. The transaction will include participation from existing investor, Xiamen Voke Mold & Plastic Engineering Co., Ltd. Out of the total funding raised, CNY 50,000,000 will go to registered capital, CNY 330,220,800 to capital reserve, and post completion its registered capital will increase from CNY 30,000,000 to CNY 80,000,000. The transaction has been approved in the 17th meeting of the company's 1st directorate and the 11th meeting of the 1st supervisory board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.24 CNY | +0.63% | -1.75% | -12.04% |
1st Jan change | Capi. | |
---|---|---|
-12.04% | 52Cr | |
+7.93% | 4.16TCr | |
-20.24% | 2.22TCr | |
-13.76% | 1.35TCr | |
-9.15% | 1.03TCr | |
-6.32% | 992.33Cr | |
+23.18% | 853.31Cr | |
+7.38% | 671.78Cr | |
-26.87% | 556.54Cr | |
-22.19% | 374.3Cr |
- Stock Market
- Equities
- 301196 Stock
- News Xiamen Voke Mold & Plastic Engineering Co., Ltd.
- Quanzhou Voke Health Industry Co., Ltd. announced that it expects to receive CNY 380.2208 million in funding from Xiamen Voke Mold & Plastic Engineering Co., Ltd.